Acquired resistance to crizotinib from a mutation in CD74-ROS1. [electronic resource]
- The New England journal of medicine 09 2013
- 1173 p. digital
Publication Type: Letter; Comment
1533-4406
10.1056/NEJMc1309091 doi
Adenocarcinoma--genetics Drug Resistance--genetics Female Humans Lung Neoplasms--genetics Protein Kinase Inhibitors--therapeutic use Protein-Tyrosine Kinases--genetics Proto-Oncogene Proteins--genetics Pyrazoles--therapeutic use Pyridines--therapeutic use Translocation, Genetic